Aprogen Medicines Inc. (KRX:007460)

Aprogen Medicines Revenue

Aprogen Medicines had revenue of 36.29B KRW in the quarter ending March 31, 2026, with 35.79% growth. This brings the company's revenue in the last twelve months to 127.54B, down -8.09% year-over-year. In the year 2025, Aprogen Medicines had annual revenue of 117.97B, down -21.41%.

• Revenue (ttm): 127.54B
• Revenue Growth: -8.09%
• P/S Ratio: 0.56
• Revenue / Employee: 498.20M
• Employees: 256
• Market Cap: 71.95B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	117.97B	-32.14B	-21.41%
Dec 31, 2024	150.11B	-464.40M	-0.31%
Dec 31, 2023	150.58B	72.23B	92.19%
Dec 31, 2022	78.35B	52.05B	197.95%
Dec 31, 2021	26.30B	-100.85B	-79.32%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 2, 2026

Data Sources Report a data error